Myriad Genetics posted Q2 revenue growth of 1% year-over-year, but adjusted for one-time events, growth would have been 5%.

Notable Drug Approvals.

Recent advancements in genomic technologies have greatly advanced our understanding of genomic regions implicated in disease processes, including ...

Thalassemia is one of the common hereditary blood disorders that impair the body’s ability to make hemoglobin and healthy red ...

Molecular testing in dermatology involves decisions about who gets tested, how to test and interpret results, and where to go ...

Th<span id="cke_bm_479S" style="display:no is study aimed to bridge that gap by conducting genetic analysis on a cohort of ...

BEIJING, China, Aug. 4, 2025 /PRNewswire/ -- METiS Technologies, a global leader in AI-driven nanodelivery innovation, today ...

Discover the facts about CLOVES syndrome—an extremely rare genetic disorder with complex symptoms and challenging diagnosis.

A global study has identified the DNA markers for stuttering, providing a genetic link that will pave the way for clinicians ...

Hair loss is extremely common, with factors such as age, childbirth, illness, medication, poor hair care, hormonal imbalance, ...

WellSpan is among 15 health care organizations participating in the project that tailors care for people who are found to be at high risk for cancers and heart disease.

A global study has identified the DNA markers for stuttering, providing a genetic link that will pave the way for clinicians ...